RhoVac announces appointment of Professor Anne J. Ridley to its Scientific Advisory Board
RhoVac AB ("RhoVac") announces today, 6[th] February 2020, the appointment of a leading oncology expert to its Scientific Advisory Board with the addition of Anne J. Ridley, PhD, Professor of Cell Biology and Head of School of Cellular and Molecular Medicine, University of Bristol, UK. Professor Ridley will serve as a strategic advisor to RhoVac as the company continues the RV001 project.Professor Ridley, PhD, joins RhoVac Scientific Advisory Board with 30 years of research experience in cancer. Her research has made major contributions to our understanding of cancer, tumour progression (